NeucaS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-15
Share capital
4 642 802,00 PLN
Activity description

Neuca is a listed company and a leader in pharmaceutical wholesale in Poland, supporting independent pharmacies. It also develops a patient-focused business under the Świat Zdrowia brand, covering medical facilities, imaging diagnostics centers and digital tools. The group also expands clinical trials activities and sustainability initiatives.

Registered address
ul. Forteczna 35-37, 87-100 Toruń, Poland
Website
inwestor.neuca.plWebsite active
Email
Email warning
Social media

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 706.00
-8.00 (-1.12%)
700.00705.00710.00715.00706.0010:0012:0014:0016:00
Open
PLN 713.00
High
PLN 714.00
Low
PLN 701.00
Volume
1.11K
Avg. vol.
17.22K
Market cap
PLN 3.28B
P/E ratio
16.66
EPS
PLN 42.38
Shares outstanding
4.64M
52-week
PLN 627.00 – 773.00
Dividend yield
2.52%
Dividend
PLN 17.80
Ex dividend date
Jun 29, 2026
ISIN
PLTRFRM00018
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 964.59mUSD 17.79mUSD 11.02m
Q1 2026USD 960.81mUSD 26.12mUSD 18.46m
Q4 2025USD 884.19mUSD 13.60mUSD 6.81m
Q3 2025USD 876.15mUSD 19.72mUSD 15.13m

Results for Q3 2026:Nov 19, 2026

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.43bnMedianUSD 874.32kAverageUSD 20.00m
Net profit
This companyUSD 39.14mMedianUSD 28.20kAverageUSD 813.32k
Operating costs
This companyUSD 3.36bnMedianUSD 803.36kAverageUSD 18.76m
Assets
This companyUSD 1.57bnMedianUSD 541.39kAverageUSD 10.63m

Industry

Bank accounts

Was a VAT taxpayer from 1994-04-01 to 2024-10-31. Removed from VAT register

Reason for removal: Art. 96 ust. 7ba (deregistration of a VAT group member upon VAT group registration)

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Nov 20, 2023Commercial Companies Code notice

Public aid

5 public aid cases recorded, with a total value of $1,461,886.

Grant datePurposeGross amountGranting body
Aug 2, 2024
De minimis aid (in accordance with Commission Regulation 2023/2831)
—Instytut Nauk Społeczno-Ekonomicznych sp. z o.o. + limited partnership
May 24, 2021
Aid for research and development projects: experimental development
—Dyrektor Narodowego Centrum Badań i Rozwoju
May 24, 2021
Aid for research and development projects: industrial research
—Dyrektor Narodowego Centrum Badań i Rozwoju

European Funds

2 projects recorded: 1 from FE lists ($1,411,569) and 1 Commission grant (FTS) ($0).

StartProjectEU co-financingProgramme
2021-04-01
Opracowanie innowacji procesowej w postaci systemu przeznaczonego do procesów kontroli jakości związanych z dystrybucją farmaceutyków i innych wyrobów medycznych
$1,411,569Program Operacyjny Inteligentny Rozwój
2018-04-01
777773 - C-voucher - circularize value chains across european regional innovation strategies
$01.1.31 - Horizon 2020

Tenders

2544 tenders recorded as contractor: 546 national ($23,047,007) and 1998 EU ($6,782,923,208).

Publication dateSubjectAmountContracting authority
Oct 2, 2026
Dostawa leków do chemioterapii i programów lekowych 2026-2028
—Wojewódzki Szpital Specjalistyczny We Wrocławiu
Oct 2, 2026
Dostawa leków programowych, onkologicznych, płynów infuzyjnych, erytropoetyny oraz kontrastów
—Wojewódzki Szpital Specjalistyczny Nr 4 w Bytomiu
Oct 2, 2026
Dostawa leków programowych, onkologicznych, płynów infuzyjnych, erytropoetyny oraz kontrastów
—Wojewódzki Szpital Specjalistyczny Nr 4 w Bytomiu

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Aleksandra Puskarz Kusa — Attorney-in-fact (joint)
Daniel Artur Wojtkiewicz — Vice President of the Management Board
Julita Monika Czyżewska — Vice President of the Management Board
Dorota Katarzyna Kruszewska — Attorney-in-fact (joint)
Roman Dudzik — Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized to submit declarations of will and represent the company.

Supervisory board

Piotr Borowski — Supervisory Board Member
Bożena Śliwa — Supervisory Board Member
Kazimierz Michał Herba — Supervisory Board Member
Wiesława Teresa Herba — Supervisory Board Member
Iwona Wanda Sierzputowska — Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the company Neuca.

Subsidiaries

NameShare valueStake
Świat ZdrowiaS.A.
1,320,907.62 USD100%
Global Pharma CmS.A.
29,713.67 USD100%
Neuca Inwestycjesp. z o.o.
113,731,320.91 USD100%

Capital group

NameOwnership
Świat Zdrowia S.A
100%
Neuca Clinical Trials Investment Sp. z o.o
100%
Farmada Transport Sp. z o.o
100%

Competitors

NameRevenueWebsite
Roche Polskasp. z o.o.$799,694,562.77roche.pl
Bayersp. z o.o.$624,313,880.67bayer.pl
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.$600,815,720.02slawex.com.pl
HurtapS.A.$480,276,955.20hurtap.com.pl
Sanofisp. z o.o.$384,123,246.36sanofi.pl
USP Zdrowiesp. z o.o.$377,149,656.94uspzdrowie.pl

Change history

DateEvent
2026-09-10Share capital change (4,626,044.00 PLN → 4,642,802.00 PLN)
2026-04-16Share capital change (4,554,344.00 PLN → 4,626,044.00 PLN)
2025-08-08Share capital change (4,552,744.00 PLN → 4,554,344.00 PLN)
2025-06-10Share capital change (4,549,444.00 PLN → 4,552,744.00 PLN)
2025-04-15Share capital change (4,542,304.00 PLN → 4,549,444.00 PLN)

FAQ

Last updated: 2026-09-10